# Delta Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/delta-medical

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.deltamedical.cn
- Total disclosed funding: $38M
- Latest round: Series E (Feb 8, 2021)
- Investors on record: 6

## About

Based in Beijing, China and founded in 2016, Delta United (Chongqing) Medical Technology Co., Ltd., together with its wholly owned subsidiary Beijing Delta Medical Science & Technology Co., Ltd. which was established in 2015 (collectively trading as Delta Medical), engage in the research, development, production, sales, and service of sports rehabilitation devices and solutions. Delta Medical has established production bases and research centers in Beijing, Sichuan, Liaoning and Chongqing, China. It has a sales network covering China and overseas regions such as Southeast Asia, Latin America, the Middle East, and Europe. 

In February 2026, Eyebright agreed to acquire a 68.31 % majority stake in Delta Medical from THG Ventures, Hengxu Capital, YuanBio Venture, Qiming Venture Partners, CDH Investments, Insight Capital and other stakeholders for approximately CNY 683 million.

Delta Medical's main products include sports medicine implants, surgical tools, supporting equipment, and postoperative rehabilitation braces, etc., providing patients with products covering the entire rehabilitation period.

The company generates revenue from sales of sports medical devices, rehabilitation products and other products.

## Funding rounds

- Series E, Feb 8, 2021, $23M — CDH Investments, Qiming Venture Partners, YuanBio Venture
- Series D, Sep 19, 2020, $15M — Qiming Venture Partners, Hillhouse Investment, YuanBio Venture, Insight Capital
- Series C, Aug 16, 2019 — Qiming Venture Partners, Insight Capital
- Series B, Apr 17, 2018 — YuanBio Venture, Insight Capital
- Series A, Sep 22, 2016 — THG Ventures

## Investors

- THG Ventures (https://capitalatlas.ai/funds/thg-ventures) — Series A
- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series B, Series D, Series E
- Insight Capital — Series B, Series C, Series D
- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series C, Series D, Series E
- Hillhouse Investment (https://capitalatlas.ai/funds/hillhouse-investment) — Series D
- CDH Investments (https://capitalatlas.ai/funds/cdh-investments) — Series E